Bronze
In2002, ATGen was founded on the belief that ‘Health is the greatest wealth’. Wealways aim to do our part in improving everyone's quality of life, whether byproviding novel diagnostic tests, developing new therapies, or providing theresearch community with quality proteins and antibodies that are crucial forlife science advancements. Based on the core SP fusion technology(Stable-peptide), ATGen’s monoclonal antibodies are manufactured in house andthis led ATGen to expand our field of expertize. ATGen started expanding intothe diagnostic market by developing an ELISA test for influenza in 2009, thenfurther developing an innovative world’s first NK cell function test called NKVue. Based on this, ATGen also launched NK mouse kit for research use and NKPuppy kit for pet dogs’ immune management. In addition, an antibody-basedgastric cancer therapy is in our next development, and through our sistercompany, NK cell therapy products are also in our development list. We areachieving the dream of becoming a world-class biotech company and striving tobecome a global leader in the healthcare industry.
NK Vue Kit, an in vitro diagnostic test that measures the activity of NK cells after activating with our patented substance Promoca, and our test has been approved in 2012 by Ministry of Food and Drug Safety in Korea. NK Vue Kit has been proved its excellence in wide range of applications, such as health checkup, cancer diagnosis, complementary diagnostics, and clinical trials.